Nuwellis, Inc., a medical device company, focuses on developing, manufacturing, and commercializing medical devices used in ultrafiltration therapy. The company's products are the Aquadex FlexFlow and Aquadex SmartFlow systems, which are indicated for the treatment of patients suffering from fluid overload who have failed diuretics. Its Aquadex FlexFlow system includes a console, disposable blood set, and catheter. The company sells its products to hospitals and clinics through its direct salesforce in the United States; and through independent specialty distributors primarily in Austria, Brazil, Czech Republic, Germany, Greece, Hong Kong, India, Israel, Italy, Romania, Singapore, Slovakia, Spain, Switzerland, Thailand, the United Arab Emirates, and the United Kingdom.[ Read More ]
The intrinsic value of one NUWE stock under the base case scenario is HIDDEN Compared to the current market price of 1.8 USD, Nuwellis, Inc. is HIDDEN
Current Assets | 8.21 M |
Cash & Short-Term Investments | 3.8 M |
Receivables | 1.95 M |
Other Current Assets | 2.46 M |
Non-Current Assets | 1.56 M |
Long-Term Investments | 0 |
PP&E | 1.44 M |
Other Non-Current Assets | 120 K |
Current Liabilities | 3.17 M |
Accounts Payable | 2.38 M |
Short-Term Debt | 432 K |
Other Current Liabilities | 360 K |
Non-Current Liabilities | 3.39 M |
Long-Term Debt | 544 K |
Other Non-Current Liabilities | 2.84 M |
Revenue | 8.86 M |
Cost Of Revenue | 3.88 M |
Gross Profit | 4.98 M |
Operating Expenses | 22.6 M |
Operating Income | -17.6 M |
Other Expenses | 2.58 M |
Net Income | -20.2 M |
Net Income | -20.2 M |
Depreciation & Amortization | 362 K |
Capital Expenditures | -248 K |
Stock-Based Compensation | 670 K |
Change in Working Capital | -1.42 M |
Others | 2.59 M |
Free Cash Flow | -18.2 M |
Date | Value | Insider | Amount | Avg Price |
---|---|---|---|---|
1 year ago
Mar 15, 2023
|
Bought 19.6 K USD
|
Jaramillo Nestor Jr.
President and CEO |
+ 4098
|
4.79 USD |
5 years ago
Mar 12, 2019
|
Bought 50 K USD
|
ERB JOHN L
CEO and President |
+ 9523
|
5.25 USD |
5 years ago
Mar 12, 2019
|
Bought 50 K USD
|
ERB JOHN L
CEO and President |
+ 9523
|
5.25 USD |
5 years ago
Mar 12, 2019
|
Bought 50 K USD
|
ERB JOHN L
CEO and President |
+ 9523
|
5.25 USD |
6 years ago
Aug 10, 2018
|
Sell 74.4 USD
|
WALLER GREGORY D
Director |
- 72
|
1.0338 USD |
6 years ago
Jul 03, 2018
|
Bought 50 K USD
|
ERB JOHN L
|
+ 23584
|
2.12 USD |
6 years ago
Nov 22, 2017
|
Bought 450 USD
|
ERB JOHN L
CEO and President |
+ 100
|
4.5 USD |
6 years ago
Nov 22, 2017
|
Bought 450 USD
|
ERB JOHN L
CEO and President |
+ 100
|
4.5 USD |
6 years ago
Nov 22, 2017
|
Bought 450 USD
|
ERB JOHN L
CEO and President |
+ 100
|
4.5 USD |
7 years ago
Oct 12, 2017
|
Bought 14.5 K USD
|
Choi Ki Yong
10 percent owner |
+ 30141
|
0.48 USD |
7 years ago
Oct 11, 2017
|
Bought 17.6 K USD
|
Choi Ki Yong
10 percent owner |
+ 31504
|
0.56 USD |
7 years ago
Sep 13, 2017
|
Bought 50.1 K USD
|
Choi Ki Yong
10 percent owner |
+ 78211
|
0.64 USD |
7 years ago
Aug 10, 2017
|
Bought 8.48 K USD
|
Choi Ki Yong
10 percent owner |
+ 13253
|
0.64 USD |
7 years ago
Aug 08, 2017
|
Bought 140 K USD
|
Choi Ki Yong
10 percent owner |
+ 180000
|
0.78 USD |
7 years ago
Apr 19, 2017
|
Bought 100 K USD
|
ERB JOHN L
CEO and President |
+ 100000
|
1 USD |
7 years ago
Apr 19, 2017
|
Bought 110 K USD
|
ERB JOHN L
CEO and President |
+ 100000
|
1.1 USD |
7 years ago
Nov 28, 2016
|
Bought 17.6 K USD
|
ERB JOHN L
CEO & President |
+ 80000
|
0.2196 USD |
8 years ago
Mar 16, 2016
|
Bought 2.28 K USD
|
ERB JOHN L
CEO and President |
+ 2500
|
0.91 USD |
8 years ago
Mar 15, 2016
|
Bought 7.6 K USD
|
ERB JOHN L
CEO and President |
+ 8000
|
0.95 USD |
8 years ago
Mar 14, 2016
|
Bought 6.88 K USD
|
ERB JOHN L
CEO and President |
+ 8000
|
0.8604 USD |
9 years ago
Aug 11, 2015
|
Bought 25.5 K USD
|
BUCKMAN PAUL
Director |
+ 10000
|
2.55 USD |
10 years ago
Mar 17, 2014
|
Bought 12.4 K USD
|
MATHIESEN JEFFREY S
Chief Financial Officer |
+ 2000
|
6.1799 USD |